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1 
Introduction 
  
Struggle to Catch Up with the Autoimmune Epidemic 
  
 Susannah woke up one morning in a hospital bed. While this would be an 
alarming experience for anyone who can’t remember the events prior to landing oneself 
in an unknown medical facility, it was all the worse for Susannah who’s first groggy sight 
upon opening her eyes was a bracelet strapped to her own wrist labeled “flight risk.” As 
the panic set in and she attempted to flail about in the bed, she was only met with the 
terrifying freeze of paralysis. She abruptly became aware of the straps restraining her to 
the bed, cutting into her arms, physically restricting her from gathering more information 
on where she was, how she got there, and why she was there. Seconds later she tried to 
cry out for help, only to realize she had no voice, her throat choking on thin air through 
attempted screams for even the slightest sign of familiarity. Little did she know, 
Savannah was under close guard by hospital staff who at the moment were combing 
through stacks of medical records detailing the hallucinations, delusions, memory loss, 
and violent outbursts Susannah had been experiencing over the last month, searching for 
any thread tying her bizarre set of symptoms together. Despite starting an exciting 
journalism career for the New Yorker and anxiously pursuing her first serious romantic 
relationship just weeks prior, Susannah Cahalan had suddenly woken up to her worst 
nightmare. Her recollection of her personal dissention into a month of madness described 
in her book “Brain on Fire” is truly haunting in its implications for all of us. 
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 In 2009, Susannah Cahalan was the 217th patient to be diagnosed with anti-
NMDA receptor encephalitis in the United States (Cahalan, 2012). While this disease was 
only just identified in 2007 as an autoimmune disease which causes acute brain 
inflammation, it doesn’t mean it hasn’t been wreaking havoc upon lives for decades 
before its official naming (Ahmad et al., 2017). After a month of personal hell, Susannah 
herself was prompted to ask the question we are all wondering, “how many people 
throughout history suffered from my disease and others like it but went untreated?” 
(Cahalan, 2012, p. 221). The answer is not optimistic as one would hope, as Cahalan 
explains, “even though the disease was discovered in 2007, some doctors I spoke to 
believe that it’s been around at least as long as humanity has” (Cahalan, 2012, p. 221). 
Even more problematic is the fact that although anti-NMDA receptor encephalitis was 
identified as an autoimmune disease two whole years prior to the day Susannah 
encountered symptoms, its recognition and etiologic understanding throughout the 
medical community did not save her from a lengthy month of misdiagnoses. The grueling 
thirty one days consisted of countless doctors dismissing her symptoms, arguing that they 
were caused by psychological phenomenon, blaming it on psychosis, and completely 
ignoring the possibility that she may actually be suffering from a physiologic disease.  
 Although Susannah Cahalan’s tragic story is becoming more widely known 
through its publication as a gripping autobiographic New York Times bestseller in 2012 
entitled Brain On Fire: My Month of Madness, this does not translate into popular 
awareness of similar widespread injustices occurring in our healthcare system today. In 
fact, many of us would prefer to turn a blind eye toward the terrifying reality that science 
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and medicine may not be prepared to treat us when the inevitable moment comes that our 
bodies decide to rebel against us. I, like many other Americans who have an unwavering 
faith in our advanced medical system, considered Susannah’s story to be a tragic, rare 
example of one unlucky patient whose complex symptoms fell through the miniscule 
cracks in our now approaching foolproof protocol to obtaining a medical diagnosis. As a 
scientist and aspiring medical researcher myself, I spent the majority of my life 
subscribing to the common belief that doctors are the omniscient beings with all of the 
answers that their patients seek. Sure, they make mistakes from time to time, as this, no 
matter how annoying, is an unavoidable truth of the human condition. However, even the 
most complex, mindboggling set of unexplained symptoms could never defeat 12+ years 
of secondary schooling, a plethora of biomedical research, and hierarchy of medical 
specialists that each doctor wields in their bulletproof arsenal. At least, that’s what I used 
to think. Now, after personal experience and academic research, I have never in my life 
been so eagerly able to admit that I was wrong.  
 Susannah is just one of the thousands of women each year who wake up one 
morning trapped between a debilitating illness and a medical system polluted with a 
centuries long gender bias that is not only ill-equipped to treat them, but at times even 
unwilling to believe them. If you subscribe to the same blind faith in science and 
medicine that I so recently began to question and are doubtful of this preposterous 
statement that challenges the very discipline that saves countless lives every year, firstly, 
I don’t blame you. Secondly, I strongly suggest you investigate the perplexing statistics 
and testimonials that begin to unravel the mystery behind the autoimmune epidemic in 
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the United States. While many would like to brush over the fact that our medical system 
may not be prepared to diagnose and treat every demographic of society with the same 
empathy, diligence, and success, we owe a deeper investigation to those who have 
experienced firsthand the wrath of medicine’s engrained bias. For those of us who have 
had the privilege of escaping medicine’s limitations, we may still be clinging to the 
assumption that whenever the inevitable moment strikes that our bodies decide to turn 
against us, doctors will undoubtedly be able to put us back together. For those among the 
9.8 million women in the US diagnosed with a common autoimmune disease, the 
inequity and ill preparedness of healthcare may come as a severe slap in the face (Lahita 
& Yalof, 2005).  
 Autoimmune diseases are one of the most striking examples of the inequity of our 
healthcare system, as their incidences in women comprise 78% of the autoimmune 
patient population, but even more concerning, so do their misdiagnoses (Fairweather & 
Rose, 2004). To illustrate, it takes a female autoimmune patient to see an average of six 
doctors before obtaining the correct diagnosis, over the course of five years in half of all 
cases (Nakazawa, 2008). Additionally, before a correct diagnosis is finally within grasp, 
it is likely the patient may be labeled a “hypochondriac” or “chronic complainer” 
(Dusenbery, 2018). In fact, 45 percent of patients with autoimmune diseases have been 
labeled as hypochondriacs in the earliest stages of their illnesses, according to a survey 
by The American Autoimmune Related Diseases Association (AARDA, 2001). This can 
lead to unnecessary long-term patient suffering, and also severe psychological damage. 
Repeated dismissal can influence feelings of isolation, paranoia, and worst of all 
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hopelessness that there isn’t a treatment that will ever work, all while patients’ physical 
symptoms worsen. Moreover, it is a vicious cycle so to speak in that many autoimmune 
symptoms are worsened by stress. The increased stress of being repeatedly stripped of a 
diagnosis can induce the release of stress related hormones and other compounds such as 
cytokines, which in turn increase the detrimental inflammation that can compound 
autoimmune patients’ symptoms (Stojanovich & Marisavljevich, 2008).  
 Antiphospholipid antibody syndrome (APS) and anti-NMDA receptor 
encephalitis (ANRE) are both diseases that exemplify the public health issue of 
misdiagnosis of autoimmune diseases. They are in a disease category along with nearly 
one hundred others that have only started being understood on a molecular level during 
the past twenty years (Nakazawa, 2008). However, this recent understanding is not due to 
the rarity in instances of contraction as one may first think. To illustrate, as many as a 
quarter of women with recurrent miscarriages end up being diagnosed with the 
autoimmune disease antiphospholipid antibody syndrome, making it more prevalent in 
women than leukemia and ovarian cancer combined (Nakazawa, 2008, p. 23). Our lack of 
previous knowledge regarding these two diseases can be attributed, however, to the fact 
that both disorders have historically been misdiagnosed by the medical community as 
either hysteria or demonic possession (Uszkalo, 2012). As diseases that are 
disproportionally suffered by women and ones that commonly cause complex neurologic 
symptoms such as hallucinations and memory loss, they both exhibit the main criteria 
previously affiliated with the hysteria diagnosis. As we have witnessed from the story of 
Susannah Cahalan who presented symptoms of anti-NMDA receptor encephalitis after its 
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official classification as an autoimmune disorder, yet still had to endure a month of 
excruciating pain prior to alleviation via correct diagnosis, other patients still experience 
the wrath of stereotypes affiliated with these diseases on their own quest to a cure 
(Cahalan, 2012).  
 Despite being extremely vulnerable to the current fad of psychogenic diagnosis, 
both antiphospholipid antibody syndrome and anti-NMDA receptor encephalitis have 
well understood molecular autoimmune pathologies. It is crucial to understand the basis 
of these conditions as they are epitomes of molecular biology combating the 
pseudoscience of hysteria and a medical system polluted with bias. Thus, I will explore 
antiphospholipid antibody syndrome and anti-NMDA receptor encephalitis’s etiologic 
transition from psychologic to its correct physiologic explanation from a molecular 
biology perspective. I will then apply this research to another, more poorly understood 
condition, fibromyalgia, a disorder that is currently classified as “psychogenic,” yet is 
hypothesized to be autoimmune. It still isn’t well understood, partly due to the fact that 
patients still face the stigma of hysteria when seeking a diagnosis. The purpose of this 
thesis is to combine biological and historical perspectives of medicine to explore the 
dangerous implications of labeling diseases as psychogenic, as this term often is merely a 
resurrection of the gender-biased concept of hysteria that impedes the diagnosis process 
on a daily basis. The dismissal of these conditions’ true etiology illuminates the 
resurgence of hysteria as an acceptable medical diagnosis, revealing the urgency to 
emphasize the molecular forces underlying previously misunderstood diseases of anti-
phospholipid antibody syndrome and anti-NMDA receptor encephalitis. Perhaps this 
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return to an enriched understanding of the biological phenomenon of autoimmune 
diseases will refocus the medical communities’ efforts in further investigating the 
molecular causes of unexplained symptoms of fibromyalgia, rather than categorizing it as 
a psychogenic condition. 
 
History of Hysteria: Medicine Becoming a Profession 
 Although a primarily scientific inquiry into the background of two recently 
understood autoimmune diseases anti-phospholipid antibody syndrome (APS) and anti-
NMDA receptor encephalitis, it would be a disservice to neglect the historical changes in 
attitudes toward women, toward medicine, and toward the understanding of disease itself 
that was influenced by the hysterical explanation of these diseases. Despite questionable 
scientific accuracy, the richness of history of surrounding hysteria throughout its 4,000 
documented years of prevalence cannot be denied (Tasca et al., 2012). It was in fact, the 
first mental disorder described to afflict women in the second millennium BC, with 
Hippocrates being one of the first to document the term, taking inspiration from the 
Greek word for uterus, hystera (Gilman et al, 1993). Some even argue that the idea of 
hysteria dates far prior to the ancient Grecian Father of Medicine. Ilza Veith, in her 
published history of hysteria, noted that although not given an explicit name at the time, 
the Egyptian papyri describes medical disturbances resulting from the movement of the 
womb (Veith, 1965).  
 While our modern definition of this medical diagnosis does not specifically refer 
to afflictions of the uterus parallel to the ancient understanding, Western medical practice 
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did attribute symptoms of anxiety, dissociated sensory loss, shortness of breath, and 
insomnia to “a wandering uterus” through the nineteenth century (Freidman, 2010). It 
does not take much research however, to realize that the scientific validity of hysteria has 
been debunked on countless occasions since its heyday in nineteenth and early twentieth 
century modern medicine (Gilman et al., 1993). Now a diagnosis deemed unacceptable 
within the medical community, there have been multiple studies conducted whose aim is 
to retroactively explain the symptoms of patients previously diagnosed with hysteria.   
 It has been found that many previous hysterical diagnoses were in fact 
presentations of various autoimmune diseases. To illustrate, one 2010 study looked at a 
pool of females experiencing symptoms commonly associated with hysteria symptoms. It 
was found that a “large percentage [of hysteria diagnoses], varying from 30-50%, 
ultimately were explained as the result of organic lesions. Neurological patients were 
found to have [multiple sclerosis] or unusual, but clearly organic, forms of epilepsy. 
Gastrointestinal symptoms were explained by inflammatory bowel disease. Systemic 
lupus erythematosus and other autoimmune disorders became apparent. Metabolic 
derangements became identifiable, and these, in retrospect, explained the earlier 
symptoms” (Freidman, 2010, p. 2). Unfortunately, even as these corrective studies are 
made, women such as Susannah Cahalan still experience dismissal of unexplained 
neurologic symptoms as the ideology of hysteria lives on. 
 How is this possible? How can such an obvious gender gap still exist within our 
healthcare system in times of prolific twenty first century technological medical advances 
and bounds made toward gender equality? The answer is largely lies in the murky history 
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of medicine becoming a profession. There is a two-fold phenomenon in this history that 
contributes to the neglect of female dominated diseases such as autoimmune disorders. 
Firstly, it is widely acknowledged that there is a knowledge gap in female conditions. 
One reason for this is that the professional medical system was largely male-dominated 
until the late twentieth century. Despite women being the predominant healers of the 
colonial era, the prevention of women from attaining formal medical education restricted 
them from the professional market until 1847, when Elizabeth Blackwell became the first 
female to be admitted to medical school (More, 1987). The increase in females in 
professional medicine was not as steep as one would expect after this historic date. Due 
to educational reform in 1910 called for by the American Medical Association, a large 
majority of medical schools educating women and minorities were closed, resulting in a 
puny 2.9% of medical graduates being female in 1915 (Flexner, 1910). Growth remained 
relatively stagnant throughout the 50s, with only 6% of the physician workforce being 
comprised by women in 1949.  Statistics slightly improved with the passing of Title IX of 
the Education Amendments, and by 1990, the number of females in the physician 
workforce reached 17% (Staff Care, 2015).  
 Even after this historic era, when the number of female doctors began to rise in 
medical schools and in practice alike, men still maintained the majority of positions of 
authority. These positions included directors of hospitals and research institutions, those 
who have the most power regarding where research funding is appointed. Bernadine 
Healy, a revolutionist in the study of women’s health, was appointed as the first female 
director of the National Institutes of Health in 1991. Before her spearheading of The 
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Women's Health Initiative, a $625 million effort to study the causes, prevention, and 
cures of diseases that affect women at midlife and beyond, research funds were directed 
to the causes deemed most urgent by the white males in power at the time. Thus, studies 
were, even comically at times, exclusive of disease categories such as autoimmune 
diseases that are suffered by majority women. For example, a Rockefeller University 
study funded by the NIH in the sixties aimed to observe how breast and uterine cancers 
were affected by obesity. The comical aspect of this study is illuminated when looking at 
its pool of study subjects, which shows that not a single woman was enrolled (Dusenbery, 
2018). In modern times, is easier to maintain a lighthearted mindset regarding this 
phenomenon of the history of medicine, as recent studies have shown efforts to close the 
knowledge gap in women’s health have been extremely successful. However, one group 
of diseases not showing an improvement in the knowledge-gap have been autoimmune 
disorders. Why does this disease class lag behind the others in its biomedical research 
and understanding within the medical community? To answer, we must again turn to the 
history of medicine as a profession.  
 Despite the gender knowledge gap being a large contributor to the problem of 
misdiagnosis of autoimmune conditions, I would like to focus on a second phenomenon 
of the early days of medicine becoming a profession. This anomaly is that diseases with 
inexplicable symptoms experienced by majority women were commonly dismissed by 
the male-dominated medical community as “hysteria,” leading to a distrust of female 
autoimmune patients ever since the concept’s indoctrination in medicine. While hysteria 
eventually came to be known as an affliction of both sexes by Sigmund Freud, hysteria 
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clearly has a gender stereotype engrained within the very being of its name, as it is 
derived from the Greek word for uterus, hystera (Tasca et al., 2012). This diagnosis has 
carried a negative connotation since its first description in the second millennium BC, 
morphing by the end of the nineteenth century into one that attributes the source of 
women’s symptoms as purely psychological (Tasca et al., 2012). 
  In our increasing age of technology, doctors can frequently give an accurate 
diagnosis to a patient after just a few objective tests. When symptoms are not as clear, 
and these objective tests and technological scans do not immediately reveal concrete 
results, doctors often take the easy way out which is to blame the symptoms on the mind. 
While the concept of “hysteria” has proven to be a pseudoscience, with no basis in 
physiological fact, it has not stopped the idea of the cause of illness being blamed on the 
mind. Essentially, the concept of hysteria, while a seemingly outdated and sexist concept 
of the past at first glance, still runs rampant in the medical community today, just 
renamed as the less overtly problematic terms “medically unexplained symptoms” and 
“psychogenic diseases.” The jargon has changed, but the ideology remains apparent for 
diseases presenting with complex neurological symptoms not quickly explained with 
objective tests. Furthermore, the stereotype that women are more prone to these 
unexplainable diseases of the mind than men has carried on far past the use of the term 
hysteria. In fact, patients today still face challenges in seeking a diagnosis and treatment 
of certain autoimmune diseases especially, and they are the epitome of a medical system 
hindered by a sexist, pseudoscientific ideology far overdue.  
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I 
 
Antiphospholipid Antibody Syndrome 
 
Demons in the Womb 
  15th century Europe was a barbaric time in many respects of medicine, but it was 
especially so for women experiencing infertility. Stories of patients experiencing 
infertility or spontaneous miscarriage are described in horrifying detail in The Malleus 
Maleficarum by Heinrich Kramer and James Sprenger, discredited Catholic clergymen of 
the era. This book, which translates most commonly to “The Hammer of Witches,” was 
published in 1487 in Speyer, Germany. Despite the fact that the unethical book was 
condemned by the top theologians of the Inquisition at the Faculty of Cologne because of 
its clear contradiction of the “true” Catholic doctrines of demonology, the book’s 
attributions of infertility to witches and demonic possession became common household 
beliefs. To most people’s astonishment today, The Malleus Maleficarum even became the 
second-bestselling book in 15th century Europe. It retained this popularity for 200 years 
after its publication, falling in sales only behind the Bible itself. Because of this 
popularity, The Malleus Maleficarum had one of the strongest influences on cultural 
views of infertility and spontaneous miscarriage that informed medical practices of the 
times (Sprenger, 1487).  
 Documentation in The Malleus Maleficarum of the treatment of women suspected 
of being infertile or those who had experienced spontaneous miscarriage are horrific. For 
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example, the text describes “a most notorious witch, who could at all times and by a mere 
touch bewitch women and cause an abortion” (Sprenger, 1487). One specific story was 
told about a pregnant wife of nobleman who was threatened not to leave the castle in case 
of coming across this fearful witch. However, she disobeyed recommendations and was 
tempted into attending a gathering among her friends. Upon entering this gathering, a 
woman approached the pregnant wife, and gently touched her stomach. Suddenly, the 
pregnant wife, “felt the child moving in pain.” This pain continued and increased to 
unbearable severity of cramping. At the alarm of all of her friends, a heavy flow of blood 
began to expel, and the pregnant woman was rushed home for treatment from the castle’s 
midwife. However, The Malleus Maleficarum graphically reads that any medical 
intervention would have been too late,  
 
“‘Alas! you have already lost your child.’ And so it proved when her time came; 
for she gave birth, not to an entire abortion, but little by little to separate 
fragments of its head and feet and hands. And the great affliction was permitted 
by God to punish her husband, whose duty it was to bring witches to justice and 
avenge their injuries to the Creator” (Sprenger, 1487). 
 
This is just one of the many incidences of this popular ancient text attributing 
women’s’ afflictions of infertility and spontaneous miscarriage to witchcraft. More 
generally, it inspired a popular belief in the 15th century that women who were repeatedly 
unable to conceive were possessed by the devil. It contains lengthy passages referring to 
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the “Incubi,” a demon in male form who seduces sleeping women, perpetually making 
their reproductive organs “useless.” Throughout the entire lengthy document there is 
never a single attribution of infertility to a physiological cause, instead one finds repeated 
assertion of the devil’s intervention in “poisoning the seed, or cooling the ardor between 
man and wife” in all patients suffering from devastating infertility (Sprenger, 1487).  
After the text explains the role of demons in matters of infertility, it goes on to 
place further blame on female patients themselves. For example, it asserts that women are 
more susceptible to demonic temptations through “manifold weaknesses of their gender.” 
Women unable to conceive even after devoted prayer to St. Anne, patron saint of the 
infertile, were almost lucky if they were accused of demonic possession (Gillman, 1993). 
At least these women were subjected to further religious purification, unlike those 
actually accused of being witches themselves. Being condemned for witchcraft was 
definitely less fortunate, as it was as equivalent to a death sentence as the diagnosis of 
stage four cancer is today. At the encouragement of the Maleus Maleficarum, witches 
were frequently burned at the stake or drowned, all because of underlying medical 
conditions preventing them from baring children.  
While the Maleus Maleficarum promoted burning these shunned “witches” at the 
stake or subjecting them to lengthy exorcisms, those who avoided this fate were instead 
forced into torturous “cures” for their infertility by medieval physicians. The fact that 
these patients, already traumatized from the heartbreaking and physiologically taxing 
reality of losing their pregnancy, were willing to undergo such agonizing treatments in 
order to conceive speaks to just how dire the situation actually was for those suffering 
    
15 
 
from infertility (Gillman, 1993). These excruciating treatments are documented in a 12th 
century book called The Trotula which translates simply to “Gynecology.” This popular 
reference novel for medieval physicians recommend choking the necks of women 
suffering from “uterine suffocation.” This “treatment” was thought to return the womb its 
correct anatomical position in the body conducive for carrying a child (Nezhat, 2012). In 
addition to pain, women also went to unthinkable lengths of discomfort in order to be 
proved fertile. A common one was drinking the urine and blood of pregnant animals. 
According to a 15th century conglomeration of medical potions entitled The Liber de 
Diversis Medicinis, "If a man wishes that a woman will conceive a child soon, take 
catmint [catnip] and boil it with wine until it is reduced to a third of its original volume, 
and give it to them to drink on an empty stomach for three days” (Ogden, 1939). 
Obviously none of these methods were rooted in scientific fact, and those quietly 
suffering from yet-to-be-identified diseases often turned to these unfounded “cures” just 
in order to escape persecution for witchcraft. 
 
 
Clots of Doom 
Jan Pankey was no stranger to the extreme stress of medical emergencies. 
Although frequently faced with the stress of making life or death decisions on behalf of 
her heartbreakingly young patients, she handled even the most confounding of medical 
enigmas with calmness and ease. She has woken up every day for the past 20 years to 
continue her dream job at Oakland’s Children’s Hospital where she exuded confidence in 
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the operating room as a pediatric and neonatal anesthesiologist. Her experience in 
combating challenging medical situations with a calm, cool, and collected attitude did not 
stop there. Jan maintained in an even more high-stakes position as a proud member of a 
physician-run medical team who completed missions overseas in helping children in 
developing countries receive lifesaving operations unattainable from their local medical 
facilities. With this extensive of training in the most critical of emergencies, one could 
not think of single a medical scenario that could even begin to phase Jan Pankey. At least 
that’s what she thought at the time. However, one summer night in 2003, Jan’s entire 
world would be turned upside down, and for the first time in her entire life, she was 
completely stripped of her ingrained confidence that our medical system could do 
anything to save her (Nakazawa, 2016). 
On that fateful night in 2003, Jan awoke just before midnight in an Idaho hotel 
room, a midway stop on her and her husband’s road trip to Montana for vacation. She 
was suddenly thrust out of her sleep by an intense burning sensation that took over her 
entire body. Upon trying to stand up, Jan realized that she couldn’t even feel the floor 
beneath her feet. Somewhere between the agonizing pain and her struggle to fill her lungs 
with the shallowest of breaths, she had passed out and woke up to her husband soundly 
sleeping in the hotel bed. Jan used every last drop of strength to crawl to the side of the 
bed to wake him up for help, meanwhile the sensation that she was being burned alive 
from the inside out was increasing with such rapidity that the thought that these could be 
her last moments on earth definitely crossed her mind. Jan’s husband David woke up to 
the horror of seeing his wife writhing on the ground in pain, a complete shock to her 
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completely healthy state just hours prior. In fact, Jan lead such a healthy lifestyle that in 
her yearly physical she was above-average in most measures predictive of relative health 
compared to her female peers also in mid-life stages. After all, the reason for Jan and 
David’s trek to Montana was to complete a hundred-plus mile bike ride through Glacier 
National Park. A doctor himself, David struggled to find any reason that his wife, the 
prosopopoeial of an active lifestyle, would be suddenly overcome with such debilitating 
pain.  
As the light of the rising sun began to spill through the curtains of the hotel room, 
Jan’s bewildering symptoms began to subside. Against her husband’s wishes, they piled 
into their station wagon, strapped the bikes on top, and forged on to reach their final 
destination of Glacier National Park. As they crossed the border into Montana, black 
smoke from the approaching wild-fires began to spill into the car. They had been raging 
for days, but Jan and David had made the pact that this natural disaster would not ruin 
their trip which had required a whole year of planning. However, minutes after the smoke 
became so thick to impede visibility, Jan’s symptoms returned with a vengeance. Despite 
much reluctance from Jan herself, David drove her to the nearest emergency room for 
evaluation. 
X-rays, urinalysis, and sets of basic vitals could not reveal anything out of the 
ordinary despite some slight shading around the lungs above the left half of Jan’s 
diaphragm. The ER doctor did not seem phased by the slight anomaly and chalked the 
whole episode up to a flare-up in Jan’s gastroesophageal reflux disease which was 
causing muscle strain along her chest wall. A dose of Prilosec should do, he thought. 
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Once again, Jan’s stubbornness combined with her experience as a medical professional 
imparting a tendency to be unphased even by severe symptoms, convinced her husband to 
continue on their journey. They started the first leg of their cycling loop the next 
morning. All was well until something broke Jan’s attention from the breathtaking views 
of the national park. From the tiny, innocuous hole of the IV insertion point administered 
the day prior in the ER grew a sinister red line that crawled all the way up her arm and 
radiated heat to the touch. Not one to ignore the signs of something as serious as a blood 
clot, Jan and David prematurely ended their trip and rushed home to get to a medical 
center they trusted. 
In the ER of their home city of Albuquerque, New Mexico, the Pankey’s 
witnessed one of the most alarming X-rays either of them had ever seen in their 
combined 40 years in the medical field. Jan’s lung scan revealed that over 50% of oxygen 
flow to her lungs had been cut off by pulmonary emboli. Further ultrasound revealed that 
her entire right leg was suffering from deep vein thrombosis, occluding blood flow from 
ankle to groin. Furthermore, small chunks of this enormous clot were breaking off at 
alarming rate and traveling straight to the lungs where they cut off more and more of 
Jan’s blood supply. Finding no cause for the clots, after six days in the hospital, Jan was 
discharged with doses of blood thinners large enough that she began to develop deep 
purple bruises to the softest of touches. This high dose of blood thinners did Jan no 
favors, however, and within another week she was back in the hospital again. This time it 
was from a clot so large that as it dropped into her chest, it made the sound of the beat of 
a drum that reverberated through her lungs with an ominous thump.  
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After inserting a blood filter in the inferior vena cava of her right leg to prevent 
the emboli from traveling to her heart and lungs, Jan was once again cleared to leave the 
hospital. In addition to her life-threatening clots, after this stint in the hospital she had 
also began to experience a confusing set of symptoms that included extreme fatigue, 
shortness of breath at the most harmless activities such as walking up one flight of stairs, 
and finally, a mysterious “brain fog” that caused forgetfulness and haziness of the mind 
throughout the day. She went to see several different general physicians and internists 
who dismissed these troubling symptoms as side effects of her anticoagulants or just as 
Jan being too hyper-vigilant about her own condition stemming from her own experience 
as a doctor. However, despite this repeated dismissal, Jan Pankey knew something was 
deeply wrong inside her body, and she was not going to wait for the rest of her blood to 
gelatinize into sludge before anyone would take her seriously. 
As karma would have it, Jan ended up at a conference for work held by a 
physician who studied rare clotting disorders. His name was Dr. Alex Spyropolous, and 
Jan immediately knew he could be the answer she had been waiting for. She became his 
patient shortly after the conference, and once her blood work hit Dr. Spyropolous’ desk, 
Jan heard the words she had been so veraciously seeking, 
“I think I know what you have, Jan. Your blood work shows the exact biomarkers 
indicative of antiphospholipid antibody syndrome” (Nakazawa, 2016). 
  
 
From Demons to Antibodies 
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While seemingly disparate victims of unexplainable medical maladies of their 
times, Jan Pankey and our patient from the witch trials in the early 15th century share a 
startling multitude of commonalities. First, they could both be victims to one of the latest 
named autoimmune diseases to be sweeping our nation: Antiphospholipid Antibody 
Syndrome (APS). Secondly, despite living centuries apart, no one in their times could 
immediately pinpoint the cause of their baffling symptoms with any semblance of 
accuracy. Finally, they both share an additional similarity in the distressing way in which 
they were treated following the onset of their debilitating disease. They were both 
targeted, cursed, condemned, or told that they were psychologically crazy after accepted 
institutions of the times could not find answers to their condition. For example, our 15th 
century patient who experienced lifelong infertility and spontaneous miscarriage in 
multiple pregnancies was encouraged seek answers from religious figures. After 
countless hours of prayers were not answered, and this “cure” of religion deemed 
ineffective, she and her husband were shunned from the church, their relationship 
accused of being tainted by the devil’s prowess. Jan Pankey, over 500 years later, was 
turned away by physicians and told that her condition was all in her head despite clearly 
apparent physiological symptoms. Her own institution of medicine had dismissed her as a 
hypochondriac. Clearly, something underlies the condition of antiphospholipid antibody 
syndrome that has lingered from its occurrence in medieval times to impede its diagnosis 
today. It would be years before this devastating condition would be understood on a 
molecular level, transformed from a stigma of demonic possession to its accepted 
reputation as one of the most common autoimmune diseases in today’s society.  
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 Antiphospholipid antibody syndrome is also known as Hughes Syndrome, named 
after the doctor who in 1983 noticed his patients experiencing an eerily similar pattern of 
symptoms as the more well-known autoimmune disease lupus erythematosus (Anderson 
et al., 1989). However, unlike lupus, this syndrome was characterized by phospholipid 
antibodies. At the impetus of this discovery by Hughes, the diagnosis of APS then split 
from lupus into its own category in the same year. Because it is a rarely discussed 
condition, many assume that its frequency of incidence in the US population is fairly low. 
Unfortunately, this assumption could not be more incorrect. In fact, one in five women 
who’ve “suffered blood clots in the legs or strokes in the prime of life test positive for 
APS, making it more prevalent in women than leukemia and ovarian cancer combined” 
(Nakazawa, 2016). It does not discriminate against pregnant women either. To illustrate, 
as many as a quarter of women with recurrent miscarriages end up being diagnosed with 
the autoimmune disease. It is plausible that our patient from the 15th century suffered 
undiagnosed from the same common condition. Despite its lack of publicity and 
fundraising for further research, antiphospholipid antibody syndrome is definitely a 
public health issue whose prevalence only increases as the years pass.  
 If this disease is so common, why did doctors blatantly miss this diagnosis for our 
two patients discussed? It comes as absolutely no surprise for our patient living in 
medieval Europe, as the lack of scientific knowledge and technology prevented the 
correct diagnosis of conditions as simple as the common cold. Because of this lack of 
knowledge and resources, they used other disciplines to attribute diagnoses to diseases, 
especially religion. Religion was so intricately woven into every detail of life in that 
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century that it was often used as an explanation for mysterious medical symptoms. That 
is why our patient’s symptoms were blamed on everything from the demonic possession 
to witchcraft; medieval physicians used the very little information they had to do their 
best in diagnosis, most of which had been steeped in teachings of the Catholic Church for 
decades (Gillman, 1993). As we have seen, this became very problematic for patients 
experiencing infertility or repeated spontaneous miscarriage. Because infertility had such 
a strong religious affiliation, infertile women were passed off as being punished by God 
for their sins, or more problematically, shunned for being possessed by the Devil. We 
now know that many women with this medical problem, as many as a quarter in fact, 
could have been silently suffering from antiphospholipid antibody syndrome while being 
demonized by those very closest to them. 
 The same cannot be said about our modern patient, Jan Pankey. We have come so 
far in improving our medical knowledge and advancing technology since the 15th century 
that there is no excuse for how this diagnosis slipped through the fingers of six out of the 
seven doctors Jan Pankey saw. While it is relatively rare for extremely active, healthy, 
middle-aged women to develop pulmonary emboli, much less antiphospholipid antibody 
syndrome, the disease is still more common than rare cancers like leukemia. Thus, no 
excuses exist for patients to go months without proper diagnosis. 
In reality, it was not the rarity of the disease impeding the diagnosis, but the fact 
that this disease, like many autoimmune conditions, has only been studied on a large 
scale in the last twenty years (Gezer, 2003). Unfortunately, the murky history of this 
disease rooted in sexism and witchcraft lingered far too long, preventing a scientific drive 
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to uncover a true physiologic cause. On the positive side, we now are able to debunk the 
pseudoscience that once served as the widely accepted explanation for antiphospholipid 
antibodies’ common symptoms such as migraines, limb spasms, shortness of breath, and 
recurrent miscarriages. The scientific community has determined the molecular etiology 
of this syndrome to be autoimmune, and while this has overthrown previous attributions 
of demonic possession, a negative stigma still surrounds this disease. It is crucial to 
expand our knowledge of the physiological cause of poorly understood medical 
conditions in an effort to improve the suffering of those who cannot achieve an efficient 
diagnosis of antiphospholipid antibody syndrome. 
 
 
What is APS? 
Simply stated, autoimmune diseases occur when our bodies make the critical 
mistake of perceiving self-antigens as threatening foreign bodies. The result of this error 
is detrimental inflammation and self-destruction of our own body tissues. Which tissues 
and organs are affected, however, depends on the specific autoantibody that is created by 
our immune system contingent on the particular autoimmune disease the individual 
develops. 
Specifically, anti-phospholipid antibody syndrome affects the clotting properties 
of blood through the presence of one or more of three distinct antibodies: cardiolipin, 
anti-β2glycoprotein 1, and lupus anticoagulant. While the primary form of this disease 
occurs without the presence of other autoimmune diseases, a secondary form is also 
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common which accompanies another disease in this same class of autoimmunity, most 
often lupus erythematosus. Secondary APS patients will often produce antibodies to both 
β2glycoprotein 1 and lupus anticoagulant. APS occurs most commonly in young to 
middle-aged adults; however, it also can occur in children and the elderly in rarer cases. 
Another demographic feature is that like many autoimmune diseases, it 
disproportionately affects women in the ratio of five women to every one male patient 
(Sangle & Smock, 2011). 
 The autoimmune nature of antiphospholipid antibody syndrome is caused by the 
presence of antibodies directed against phospholipid-binding plasma proteins, mainly β2 
Glycoprotein I (β2GPI)-a plasma apolipoprotein and prothrombin. These antibodies 
attack two entities: clotting factors and platelets. Resistance to natural anticoagulants 
such as protein C, impaired fibrinolysis, activation of endothelial cells to a pro-coagulant 
phenotype and activation of platelets, are among the proposed mechanisms of how APLS 
causes thrombosis that are partially supported by experimental evidence 
(Vlachoyiannopoulos & Routsias, 2010). The clotting that results from this resistance to 
natural anticoagulants is what has given APS the common name of “sticky blood 
syndrome.” But where exactly does this fearsome antibody, one that can turn blood into 
sludge at the drop of hat, come from? It turns out that the culprit behind the production of 
anti-β2 Glycoprotein I may be lurking in the immune system weeks, months, or possibly 
even years prior to the onset of APS, leaving researchers sifting through patients’ medical 
history for the seemingly benign illness that triggered this life-threatening disease. 
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There isn’t a clear reason why one’s body begins to produce the antiphospholipid 
antibodies that result in APS, but there are theories supported by academic research. The 
latest of which explains that it is likely caused by an initial infection unrelated to the 
disease itself, in the form of a virus or bacterium. The mechanism by which this occurs 
involves the cell walls of certain bacterial cells and certain coatings of viruses are 
especially reactive with the antiphospholipid antibodies. This stealth mode of molecular 
self-destruction is termed molecular mimicry. Molecular mimicry occurs when a foreign 
antigen such as a virus or bacteria shares genomic sequence or structural similarities with 
antigens towards your own body tissues (Cusick, Libbey, Fujinami, 2013). APS is a 
disease especially vulnerable to molecular mimicry, partially because cell membranes of 
wide range of tissue cell types are made out of the same structural elements, 
phospholipids, that APS antibodies are fashioned to attack.  
Viral and bacterial mechanisms of molecular mimicry by which the body begins 
to produce APS-causing autoantibodies differ in a few crucial ways. Viruses are designed 
to destroy specific T cell types, which can cause an imbalance in the host immune 
response and autoimmunity later down the line. The most common viral infections 
associated with APS include hepatitis C virus, human immunodeficiency virus (HIV), 
cytomegalovirus, varicella-zoster, Epstein–Barr virus, adenovirus, and parvovirus B19. 
Evidence suggesting microbial agents as APS triggers is less compelling; however, in 
rarer cases microbes have been found to induce “superantigens” that can selectively 
activate similar subsets of T cells as viruses (Shoenfeld et al., 2006). Additionally, recent 
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research has proposed the production of chemokines and cytokines by certain bacteria as 
modes from which amplify the inflammatory response of the immune system. 
Shoenfeld et al. proved the molecular mimicry hypothesis as a probable 
mechanism for the development of APS antibodies through a study utilizing immunized 
mice with various microbial pathogens that share structural features with β2 Glycoprotein 
I (2006). The results were astounding. Infection with Haemophilus influenza, Neisseria 
gonorrhoeae, and tetanus toxoid, caused mice to produce antibodies that attacked their 
own β2 Glycoprotein I receptors. Increased fetal loss and thrombocytopenia, two key 
features of APS experienced by humans, were seen in this mouse model. For the first 
time, a study proved that microbial infection can induce molecular mimicry to cause APS 
in model organisms, suggesting that the same could be true in humans.   
Although molecular mimicry as a mechanism for explaining the sudden 
production of anti-β2glycoprotein 1 and anti-cardiolipin antibodies is an attractive model 
for its simplicity, it may be too simple. Cusick et al. argues that molecular mimicry could 
have been misinterpreted as a different mechanism which more accurately underlies APS. 
This mechanism is the expression of dual T cell receptors (TCR) on a single T cell. Dual 
expression is not inherently dangerous, but when these two receptors become 
simultaneously reactive to both foreign and self-antigens, our bodies can suddenly mount 
an autoimmune response when faced with an onslaught of viral or bacterial pathogens. 
However, there is also evidence showing that APS has a genetic component that 
could cause the development of this specific type of autoimmunity (Garcia et al., 2013). 
To illustrate, polymorphisms in a few genes have been found in people with 
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antiphospholipid syndrome and may predispose individuals to produce the specific 
antibodies known to contribute to the formation of thromboses. Rarely, the condition has 
been reported to run in families, but it does not have a clear pattern of inheritance as far 
as geneticist sleuths have uncovered thus far (Feldman & Levine, 1995). 
We have already seen an illustration of some of the common symptoms of 
antiphospholipid antibody syndrome from the introduction of our two patients, but there 
is a well-recognized “trifecta” of components of antiphospholipid antibody syndrome that 
define its clinical manifestation. The trifecta consists of thrombosis, otherwise known as 
blood clotting, thrombocytopenia, (low platelet count leading which causes internal 
bleeding), and recurrent miscarriage in female patients. This last symptom, arguably one 
of the most mentally devastating experiences a woman can endure throughout her 
lifetime, has been a particularly troublesome mystery for the scientific community to 
unravel. It is still somewhat unclear why and or how the antibodies indicative of APS can 
be poisonous to the placenta. What we do know, however, is that this condition 
frequently leads to a mother rejecting her placenta (Gezer, 2010).  
 
 
 
 
 
II 
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Anti-NMDA Receptor Encephalitis 
 
Unraveling the Mystery of Betty and Abigail Parris 
While the most widespread instances of accused witchcraft disseminated through 
Europe between the 14th and 17th centuries, causing the execution of tens of thousands of 
women over these centuries, the burgeoning American Colonies were not immune to the 
religious fad of demons and witches either (Blumberg, 2007). Despite this witchcraft 
mania not catching on in the colonies until the very tail end of the European era craze, 
witchcraft has a rich history on our own New England soil, one that has reignited the 
interest of modern historians and biomedical scientists alike.  
In 1692 Colonial Massachusetts, the population of which would fit into Yankee 
Stadium today, would find itself amidst one of the most dangerous social climates they 
had ever faced (Schiff, 2015). In light of their dangerous journey from England to North 
America to flee the persecution for their religious faith, the Puritans did not initially find 
the solace they were seeking. No one was safe. Family members accused each other. 
Suspicious glances flew between fellow church members. Children were ripped from 
their parents to be thrust into interrogation. In 1692, the Massachusetts Bay Colony 
executed fourteen women, five men, and two dogs for witchcraft. The minds of scientists 
and historians have been enraptured with unraveling the mystery of what could have 
possibly caused the bizarre behavior seen during the infamous Salem Witch Trials ever 
since (Zandi & Tam, 2017). 
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 In January 1662, the revered Salem Reverend Samuel Parris awoke to his worst 
nightmare. Knowing full well that witchcraft laid between idolatry and blasphemy as the 
second capital offense decided upon by the community in 1641, he was taken aback to 
see his own nine-year-old daughter, Betty, and eleven-year-old niece, Abagail, overcome 
by suspiciously “demonic” behavior (Blumberg, 2007). Their symptoms perfectly 
mimicked those described in a popular book, “Memorable Providences, Relating to 
Witchcraft and Possessions,” describing the afflictions of a family convicted of witchcraft 
just four years prior (Schiff, 2015). He shuddered in fear to realize that the “agitations, 
writhings, tumblings, tossings, wallowings, foamings” experienced by Betty and Abagail 
were even more severe than described in this fateful book. Meanwhile, the girls writhed 
in a burning sensation that overtook their entire bodies. They cried out that they were 
being repeatedly stabbed by needles or being bitten by invisible creatures. They had 
spasms in which their bodies would twitch and then become perfectly rigid. As their 
conditions deteriorated, they both frequently went into catatonic trances for which the 
Reverend prayed through all hours of the night, hoping and begging God to break them 
out of their stupor. Shortly after the onset of their bizarre behavior, another child, Ann 
Putnam, age 11, fell victim to the same symptoms, symptoms that their local doctor 
would later blame on demonic possession (Blumberg, 2007). 
 The magistrates of Salem, Jonathan Corwin and John Hathorne, pressured the 
young children for information on who could have possibly forced the Devil to enter their 
previously innocent souls (Schiff, 2015). On February 29th, the girls broke under the 
immense pressure and blamed three women for practicing witchcraft against them: 
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Tituba, a Caribbean slave, Sarah Good, a homeless beggar, and Sarah Osborne, an elderly 
impoverished woman (Baker, 2015). The community did not waste a second in jailing 
these three women for witchcraft, with only the testimony of the three afflicted children 
as their compelling evidence. Shortly after this incident, an uncontrollable wildfire of 
witchcraft paranoia spread throughout Salem. Children as young as 4 years old were 
taken in for interrogation. Even more frightening was that once you were accused, there 
was nothing you could say, no defense plausible enough, to convince the Magistrates of 
your innocence. You were already a dead woman walking (Hall, 1999). 
Under the advisement of Harvard’s then president, Increase Mather, a staunch 
Puritan and the author of that infamous witchcraft book “Remarkable Providences,” in 
May 1693, Governor William Phipps claimed that the Salem Witch Hunt had gone too 
far (Blumberg, 2007). Mather, after a dedicated lifelong battle hunting those converted by 
the devil, finally denounced the use of controversial “spectral evidence” in the trials by 
saying, "It were better that ten suspected witches should escape than one innocent person 
be condemned" (Schiff, 2015). Governor William Phipps, hearing this critique of the 
witch trials from Mather in combination with the fact that his own wife had been accused 
of witchcraft, banned the future arrest of any accused of witchcraft and released many of 
those previously convicted from jail (Baker, 2015).  
However, it was far too late. 19 people were already hanged on Gallows Hill, a 
71-year-old man was crushed with heavy stones, many convicted had already died in jail, 
and 185 witches had been exiled for their suspected allegiance to the devil (Schiff, 2015). 
Much has been left to the imagination regarding the fates of the little Betty and Abigail 
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Parris, the first to come down with symptoms of demonic possession. Any written record 
of Abigail disappears after 1692, leaving many questions about her life, or possibly lack-
thereof, after the trials (Baker, 2015). What is certain, however, is that these two children 
were jailed for their conditions, and in addition to suffering the physical agony of their 
symptoms, at nine and eleven years old, they also suffered abrupt exile by everyone in 
their community (Blumberg, 2007). 
In 1976, a scientist named Linnda Caporael was the first to suggest a biomedical 
cause for the seemingly unexplainable events that unfolded in Salem in 1692. She 
proposed that those who were accused of witchcraft had consumed grain contaminated 
with the fungus Claviceps purpurea, which caused convulsive ergotism, a condition 
marked by the clinical features of muscle twitching and spasms, changes in mental state, 
hallucinations, sweating, and fever (Caporael, 1976). This was the first attempt at 
explaining the confusing events of 17th century Salem with a physiological disease. 
Although this theory is not widely accepted by today’s historians, it sparked numerous 
studies into possible medical explanations of historical witchcraft epidemics. For 
example, Carlson et al. proposed encephalitis lethargica as a condition afflicting those in 
Salem. However, the most recent, and possibly the most striking resemblance of 
symptoms to those experienced by Betty and Abigail Parris is anti-NMDA receptor 
encephalitis (Zandi & Tam, 2017). A 2012 study by historian KC Uszkalo, suggests that 
the European witchcraft craze was caused by this rare autoimmune condition. Due to the 
strong overlap of events between the witch trials in Europe and in Salem, this theory has 
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caught traction among scientists and historians to describe the events in Colonial 
Massachusetts as well (Uszkalo, 2012).  
 
“Demonic Possession” in the Modern Age 
“There likely was a pathogen of some sort that had invaded my body, a little germ 
that set everything in motion. Maybe it came from that businessman who had sneezed on 
me in the subway a few days before, releasing millions of virus particles onto the rest of 
us in that subway car? Or maybe it was in something I ate or something that slipped 
inside me through a tiny wound on my skin, maybe through one of those mysterious bug 
bites? There goes my mind again. The doctors don’t actually know how it began for me. 
What’s clear is that if that man had sneezed on you, you’d most likely just get a cold. For 
me, it flipped my universe upside down and very nearly sent me to an asylum for life” 
(Cahalan, 2012).  
 The life story of Susannah Cahalan, like many heartwarming news stories of 
miraculous patient recovery, can easily be forgotten because of its happy ending. As we 
saw earlier, Susannah Cahalan’s story has made the popular press headlines for her eye-
opening ordeal in seeking a diagnosis for her acute neurologic symptoms in 2007. We 
know from her best-selling book, Brain on Fire, My Month of Madness, that she would 
later be diagnosed as the 217th patient in the United States with Anti-NMDA encephalitis. 
However, despite the sigh of relief readers feel at the end of her novel upon the long-
awaited diagnosis and subsequent recovery, her journey to this diagnosis cannot be 
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mistaken for anything other than a long and winding road filled with confusion and 
suffering.  
Arguably the most important take-away from Susannah Cahalan’s experience is 
the fact that anti-NMDA receptor encephalitis is not the only physiological condition 
masked by seemingly unexplainable psychiatric components. In fact, Cahalan’s saving 
grace, Dr. Najjar, believes that there are many mental disorders that can be explained by 
physiologic and molecular mechanisms. His research takes the link between autoimmune 
diseases and mental illnesses one step further: “through his cutting-edge research, he 
posits that some forms of schizophrenia, bipolar disorder, obsessive-compulsive disorder, 
and depression are actually caused by inflammatory conditions in the brain” (Cahalan, 
2012). What does this mean for patients? Eerily, echoes of autoimmunity may lie behind 
many more mental health conditions than we even know. 
 Dr. Najjar’s latest publication explores the concept of “autoimmune psychosis” 
and potential clinical approaches to combat new onset psychosis associated with immune 
dysregulation (Najjar et al., 2018). This type of psychosis, Najjar and contributors argue, 
is one of the most difficult to diagnose because patients often lack structural 
abnormalities of the brain frequently seen through MRI as clear signs of physiologic 
disease. Because the root cause of autoimmune psychosis lies in various invisible 
autoantibodies towards synaptic and neuronal cell membrane proteins, the condition is 
often overlooked as psychiatric in origin rather than having a treatable organic cause. 
However, autoimmune psychosis does leave clear anatomical traces in the brain that can 
be detected through various tests including cerebrospinal fluid analysis, EEG testing, and 
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different types of neuroimaging; it is just up to physicians to notice these subtle 
abnormalities atypical of many neurologic diseases.  
The first challenge in diagnosing autoimmune psychosis is identifying 
inflammatory abnormalities connected with psychiatric symptoms. Steiner et al., utilized 
CSF analysis in a postmortem study of patients with schizophrenia to identify the one of 
the main inflammatory abnormalities associated with autoimmune psychosis is microglial 
activation. Excessive microglial activation is indicative of changes in the CNS 
microenvironment, such as the inflammatory and neurodegenerative processes that could 
cause psychiatric symptoms. Additionally, an earlier study by Dr. Najjar found that 
inflammation caused by autoantibodies  
“predominated in brain regions of functional relevance to psychosis (e.g., dorsolateral 
prefrontal, superior temporal, and anterior cingulate cortices)” (Najjar et al., 2013). This 
study also confirmed the excessive production of inflammatory mediators in some cases 
of psychosis, such as the upregulation of pro-inflammatory cytokines and matrix 
metalloproteinases. 
 What does this mean for patients? Well, like Susannah Cahalan, some patients’ 
psychosis is drug resistant to many of the anti-psychotic drugs utilized by today’s 
medical protocols. This seems rather logical because the psychosis is being caused by 
agents that anti-psychotic drugs are not intended to attack. Dr. Najjar argues that timely 
recognition of the autoimmune causes of psychosis is crucial to more effective treatment 
because anti-NMDA receptor encephalitis patients “frequently respond well to timely 
treatment with proper immune modulatory therapies” (Najjar et al., 2018). Perhaps if 
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there is a greater acceptance among the medical community of organic, autoimmune, and 
inflammatory causes of mental illness, patients could be treated in a much more efficient 
and effective manner.  
 
Debunking the Pseudoscience: What is Anti-NMDA Receptor Encephalitis? 
Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is a treatment-
responsive encephalitis associated with anti-NMDA receptor antibodies, which bind to 
the NR1/NR2 heteromers of the NMDA receptors (Hughes et al., 2010). Despite its rarity 
and common misdiagnosis within the medical community, it has a well-defined set of 
clinical manifestations which patients begin to exhibit in phases. For example, the main 
set of symptoms lie in the category of psychiatric changes which include anxiety, 
agitation, “bizarre behavior,” and paranoia. Epileptic seizures and impaired cognitive 
abilities more severely follow the noticeable psychological difference. The final 
ubiquitous symptom common between most anti-NMDA receptor encephalitis patients is 
called orofacial dyskinesia, in which involuntary movements of the face and mouth take 
over the body with a vengeance (Garcia et al., 2013). 
Physicians have categorized this progression of symptoms into three distinct 
phases: the prodromal phase, the psychotic phase, and the unresponsive phase. As their 
names imply, each phase marks the onset of a more startling set of symptoms than the 
last, representing the extent to which the encephalitis is increasing in severity. More 
worrisome is the fact that recent research has determined that as the disease progresses 
through to these late stages of unresponsiveness and hyperkinesis, the more likely it is 
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that patients will suffer from irreversible brain damage (Liu et al., 2017). The prodromal 
phase is marked by viral infection-like symptoms of fever, headache, and fatigue. The 
second phase, the psychotic phase, causes patients to experience schizophrenic-like 
symptoms of disorganized speech and behavior, or delusions and hallucinations. The 
final stage, the unresponsive phase, includes the most serious symptoms of decreased 
levels of consciousness and central hypoventilation, which could become severe enough 
to cause death by hypoxia (Maneta & Garcia, 2017).  
 From the story of Betty and Abigail Parris, the young children afflicted with 
symptoms diagnosed as the evil acts of witches, we can see that some of their symptoms 
perfectly parallel those within the well-defined set of clinical features including 
psychiatric changes (anxiety, agitation, bizarre behavior, delusional or paranoid 
thoughts), epileptic seizures and cognitive disturbance followed by movement disorders, 
alterations in the level of consciousness and dysautonomia. A recent 2017 study by Tam 
and Zandi, attempts to attribute the historical descriptions of these children’s bizarre 
actions with a corresponding clinical feature of anti-NMDA receptor encephalitis. The 
results are astounding.  
They found ten symptoms outlined in primary historical documents from 1692 
that can be explained by physiologic responses of the body to anti-NMDA receptor 
encephalitis. For example, the documentation from the time stated that the girls 
experienced, “Uttering foolish, ridiculous speeches, which neither they themselves nor 
any others could make sense of” (Calef, 1700). This can likely be attributed to the 
orofacial diskinesia of the psychotic phase of anti-NMDA receptor encephalitis. 
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Additionally, it was described that “their limbs wracked and, tormented so…their arms, 
necks, and backs turned this way and that way, and returned back again” (Lawson, 1692). 
This could possibly be referring to the convulsions and body dyskinesia caused by 
inflammation of the CNS. One of the most frightening symptoms to Reverend Parris was 
that his typically well-behaved daughter was taken over by bursts of violence. “She 
hurryed with violence to and fro in the room… and begun to throw fire brands about the 
house” (Hale, 1697). Zandi and Tam attribute this violent behavior to the behavioral 
disinhibition that frequently accompanies the disease. Finally, in the later phases of their 
illnesses, when asked questions by doctors or their families, the girls were often 
unresponsive, staring blankly as if focusing on something far in the distance. Sometimes, 
when they did manage speech, their responses were completely uncorrelated to the 
question asked, leading some to ‘‘take them as dumb’’ (Hale, 1697). This state is eerily 
similar to the states of catatonia patients experience in the unresponsive phase of anti-
NMDA receptor encephalitis (Zandi & Tam, 2017). 
Because the true cause of the bizarre conditions documented in the Salem witch 
trials will forever remain somewhat of a mystery, it is important to note that skepticism 
over whether the Parish cousins suffered from any particular disease is valid. After all, 
historians and scientists have been debating the cause of their psychosis for centuries and 
are no closer to a definitive answer. The crucial take away from this ongoing debate is 
that many of these academics agree on one telling point: Abagail and Betty likely 
suffered from an undiagnosed physiologic medical condition with a clear organic cause, 
one that the era just wasn’t equipped to uncover. We may never know if anti-NMDA 
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receptor encephalitis was the culprit, but pointing out historical inaccuracies and patient 
neglect is a step towards untying the study of psychosis from detrimental stigmas of the 
past.  
Now that researchers are beginning to draw connections between probable 
historical instances of the disease and its known symptoms today, they are also studying 
the molecular components of the disease itself with the underlying goal of more effective 
treatments and prevention. It is known that NMDA receptors are a necessary molecular 
feature of the brain that consist of ligand-gated cation channels. These channels play 
crucial roles in our regular synaptic transmission and plasticity (Dalmau et al., 2008). 
Receptors are heteromers of NR1 subunits that bind glycine and NR2 subunits that bind 
glutamate (García-Carrasco et al., 2013). Reception of these amino acids is crucial for the 
normal functioning of the central nervous system, as the CNS relies on glutamate as its 
major excitatory transmitter. However, glutamate reception is also a frequent culprit in 
the abnormal functioning of the CNS because this amino acid is also an excitotoxin when 
excessively activated, destroying CNS neurons upon reception on dendritic and somal 
surfaces (Newcomer et al., 200). Even before the formal discovery of anti-NMDA 
receptor encephalitis as a disease, it was known that increased activity of NMDA 
receptors causes excitotoxicity and is a proposed underlying mechanism for many 
neurologic conditions such as epilepsy, dementia, and stroke. However, low activity 
produces symptoms of schizophrenia. This implicated possible repercussions in the form 
of neuropsychiatric symptoms for hypoactivity of NMDA receptors, and researchers 
began to search for possible inhibitors of these crucial channels (Liu et al., 2017).  
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It has been determined that one cause of hypoactivity of NMDA receptors is 
autoimmune in nature, giving rise to anti-NMDA receptor encephalitis.  Anti-NMDA 
receptor antibodies bind to the NR1/NR2 heteromers of the NMDA receptors. Binding of 
antibodies prevents normal neuronal signaling and cause brain swelling of NMDA 
receptor Encephalitis (Hughes et al., 2010). Now that the synaptic and neuronal 
inflammatory reaction associated with psychosis in anti-NMDA receptor encephalitis is 
being connected, the question remains of how the NR1/NR2B autoantibodies are 
produced to ignite this autoimmune condition. It is not completely clear why the body 
starts producing these detrimental autoantibodies in the first place. The most recent 
research on the topic has noted a high frequency of anti-NMDA receptor encephalitis 
with ovarian teratomas has sparked study into whether malignant tumors could increase 
vulnerability to contracting the disease (Ahmad et al., 2017). Additionally, genomic 
studies have identified single-nucleotide polymorphisms in the HLA-II region of the 
genome. This suggests there may be specific mutations that lead to production of the 
NMDA receptor antibodies (Mueller et al., 2018). 
Similar to anti-phospholipid antibody syndrome, previous viral and/or bacterial 
infection has also been connected to autoantibody production in the onset of autoimmune 
psychosis. In a study on the link between autoimmunity and acute onset of schizophrenia 
found that herpes simplex virus, Toxoplasma gondii, cytomegalovirus, and influenza 
during pregnancy increase the risk of developing schizophrenia significantly (Benros et 
al., 2011). Furthermore, Benros et al. found that any history of prior hospitalization due 
to an infection increased the risk of schizophrenia by 60%. The increased risk of 
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schizophrenic manifestations of autoimmune psychosis can likely be attributed to the 
infections that induce an inflammatory response through mechanisms like molecular 
mimicry (Rice et al., 2005).  The figure below shows the significant linear trend in 
incident rate ratios of schizophrenia spectrum disorders associated with autoimmune 
disease and infection (Benros et al. 2011).  
 
 
 
 
 
 
 
 
 
Overall, Benros and contributors have proven there is a significant link between 
autoimmunity and psychosis symptoms seen in diseases primarily classified as 
psychiatric, and they have identified a likely pathology of how these antibodies are 
developed: molecular mimicry from a previous infection. Antibodies produced in anti-
NMDA receptor encephalitis could also be produced through a similar mechanism. 
Furthermore, it has been determined that autoantibodies are the cause of neurologic 
symptoms in more than just anti-NMDA receptor encephalitis. In fact, a wide array of 
autoantibodies can cause autoimmune psychosis in diseases not even primarily 
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neurologic. All that is required for psychotic disease manifestations is for autoantibodies 
to cross the blood-brain barrier. For example, in systemic lupus erythematosus, the 
crossing of antibodies over the blood-brain barrier can cause secondary neuropsychiatric 
symptoms in the affected individual (Benros et al., 2011). 
Now that much more is known about the molecular physiology that underlies anti-
NMDA autoimmune encephalitis, the current process of diagnosis is much clearer; 
however, like in Susannah Cahalan’s case, much is left up to the doctor’s intuition. The 
first step in the process is gathering a patient history. Because the disorder predominantly 
affects children and young adults, disproportionately female, symptoms resembling the 
disease progression that occur in young females should raise special alert of the 
possibility of anti-NMDA receptor encephalitis. Additionally, because many patients 
possess ovarian teratomas, a past medical history of a malignant tumors should also raise 
alarms, especially in women older than 18 years (Ahmad, et al., 2017).  
The next step in the diagnosis process is a physical examination. Due to 
neurobehavioral changes that many patients experience, doctors will conduct a 
neuropsychological examination including multiple tests. The Buschke selective 
reminding test measures verbal memory, visuospatial memory, and logical memory. A 
Trail Making A and Trail Making B test examines executive functions of patients, while 
information processing speed is tested by the symbol digit modalities test. The clock 
drawing test targets visuoconstructive abilities. In fact, Brain on Fire’s Susannah Cahalan 
was only properly diagnosed after Dr. Najjar administered the clock test, in which she 
failed to properly space out all twelve numbers over the entire clock circumference. 
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Instead, the numbers ended up jumbled and crammed into one side of the circle, 
indicating poor spatial awareness. The final neurobehavioral test is frequently a mini-
mental state examination (Vahter et al., 2014). 
 A final diagnostic marker is laboratory tests. In a 2008 case study, blood tests 
showed the presence of antibodies to NR1/NR2B heteromers of the NMDA receptors 
were in the blood serum and CSF of all patients. However, MRIs, usually a scan that can 
diagnose a multitude of neurological disorders and what is usually the first diagnostic test 
ordered when doctors are presented with psychosis cases, show completely normal 
results. Likewise, single-photon emission computed tomography also shows normal 
results, but sometimes presents with focal enhancement in the medial temporal lobes. 
Electroencephalogram monitoring during the unresponsive and hyperkinetic phases 
showed diffuse delta activity without paroxysmal discharges (Dalmau et al., 2008). The 
combination of these three objective tests can confirm a diagnosis of anti-NMDA 
receptor encephalitis, but as previously said, much is left up to the doctor’s intuition.  
Dr. Najjar recommends combating the frequency of misdiagnosis of autoimmune 
psychosis in cases like anti-NMDA receptor encephalitis by encouraging doctors stay 
alert for abnormalities inconsistent with typical psychosis. These include finding elevated 
serum levels of antibodies that target synaptic and neuronal cell membrane proteins, 
cerebrospinal fluid samples that include the same neuronal antibodies, and MRI’s 
showing certain structural abnormalities such as hippocampal inflammation consistent 
with autoimmune limbic encephalitis (Najjar et al., 2018). Finally, it is crucial that 
physicians take into account interviews of patient’s family members including asking 
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questions such as if there is a strong prevalence of autoimmune disorders or mental 
illness that runs in their family history. Overall, utilizing a “multi-modal” diagnostic 
approach to psychosis with suspected organic pathologies can more quickly reveal an 
autoimmune causation of certain psychosis cases like anti-NMDA receptor encephalitis. 
Moreover, it can prevent situations of prolonged patient suffering like Susannah 
Cahalan’s, seen all too frequently in this era of advanced medical and technological 
practice.  
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III 
 
Fibromyalgia- The Mystery Disease 
 
Getting out of bed, cooking, and going to the gym. These are three activities I 
preform on a daily basis and whose ease of completion I, like many of us, often take for 
granted. Every morning my alarm clock goes off at seven for class and despite no 
obvious impediments to my daily routine, I admittedly have to stifle groans and 
overcome the occasional magnetic attraction between my hand and the snooze button in 
order to get through my morning routine. No matter how much unwarranted self-pity I 
may muster up in my day-to-day monotonies, I continue to live most of my days content, 
fulfilled, and optimistic, while each of these insignificant inconveniences float to the back 
of my mind faster than I can finish my first cup of coffee in the morning. These minor 
inconveniences and annoyances that we face in our everyday lives are of little 
consequence to our overall qualities of life. For the patients that will later be discussed, 
getting out of bed, cooking one’s meals, and going to the gym all are momentous events 
that have at least at one time or another, caused them to spiral into health crises. 
Almost everyone has experienced that sudden jolt of interrupted REM sleep that 
physically elevates you off the calm surface of the bed at the dreaded screech of an alarm 
clock. For Adrienne Dellwo, however, being jolted awake at 7:45 sends a shiver of pain 
down her spine from head to toe, leaving her paralyzed in bed for a few more minutes. 
Finally, she gains the strength to remove the CPAP breathing machine off of her head and 
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the splint that prevents her teeth from grinding and inflaming her TMJ. She goes through 
an elaborate stretching routine to assess which parts of her body need extra attention to 
loosen up before attempting to stand. She’s crashed to the floor too many mornings 
before to forgo this mental assessment while still lying prone. Once sitting, she begins to 
beat herself up for making a crucial error in judgement the night prior: in her medically 
induced haze she forgot to place her slippers directly next to the bed. This will make her 
first steps of the day unbearable. Anticipating what’s to come, Adrienne gently places 
one foot on the carpet only to be met with the feeling of sharp granules of sandpaper. She 
takes a couple steps forward and the friction radiates unbearable pain through the soles of 
her feet. At least she’s awake now. 
Susan Ingebretson describes a different struggle with an everyday task. A lot of us 
dread going to the gym, but unlike this patient we don’t require a cane to steady ourselves 
while braving the terrain of the parking lot between our car and the grocery store. Upon 
entering her gym most days she has only one goal. She states, “Staggering on the 
treadmill like Captain Jack atop the Black Pearl, my simple goal was to stay upright. I 
gripped the weight machines for dear life and prayed for the room to stop spinning” 
(Ingebretson, 2013). Despite the pain, Susan would work out six days a week, and every 
night she would suffer excruciating leg cramps. She tried anything and everything to 
alleviate this pain. From over-the-counter anti-inflammatories to prescribed topical 
creams to endless soaks in boiling hot baths, the cramping never ceased. Regarding the 
countless combinations of potassium, magnesium, manganese, and calcium supplements 
she ingested in various cocktails, she jokes that she ate enough bananas “until I could 
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swing from trees and glugged enough chalky white concoctions to stripe a football field.” 
Even these newly acquired superpowers did not decrease her pain. Nevertheless, Susan 
continues to drag herself to the gym every morning. 
It is not waking up in the morning or going to the gym that Rachael Taylor finds 
is the most difficult task to complete on a daily basis, but instead the life-sustaining 
activity of cooking. Preparing meals is a comfort and calming pastime for many 
Americans living a healthy life; for Rachael on the other hand, it is her worst nightmare. 
There is the obvious debilitating pain, as expressed by Adrienne and Susan, but this time 
it is amplified by the need to lift, grip, and physically work heavy kitchen equipment. 
Additionally, there is the added challenge of standing for hours on end, putting immense 
strain on the back, legs, and feet. Finally, Rachael has a difficult time sifting through the 
thick brain fog long enough to see what ingredient comes next in a recipe. However, 
going without food just isn’t an option, and nutritional demands of her medically 
prescribed diet could not be fulfilled from constant delivery and take-out meals. Thus, 
Rachael had to invest time and energy into building “a path of least resistance for 
[herself] throughout the whole kitchen” just to sustain herself on the worst days of her 
condition. One quick glance at her kitchen reveals hours of intentional planning including 
the heaviest items at the most convenient level while sitting, 
Adrienne, Susan, and Rachael all have much more in common than just the 
inconvenience of having to alter their everyday tasks. They all suffer from debilitating 
pain from a mysterious illness that continues to stump the most experienced of medical 
professionals. This condition is called fibromyalgia syndrome (FMS) and as these three 
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women’s stories can attest to, the ramifications of this disease spread far beyond the 
consequences for individual patients. As we have seen from our previous discussion of 
antiphospholipid antibody syndrome, and anti-NMDA receptor encephalitis, fibromyalgia 
is a condition whose modern diagnosis is impeded by its previous classification as a 
psychogenic. Patients frequently find themselves, judged, dismissed, and left with more 
questions than answers from the very physicians meant to alleviate their chronic pain. 
 
What is Fibromyalgia? 
While there have been many terms tossed around throughout the years to describe 
chronic muscular pain, the one that has seemed to stick was coined by British neurologist 
Sir William Gowers in the early twentieth century. He described the cause of widespread 
muscle pain to be “fibrositis,” otherwise known as inflammation of the fibrous tissues of 
the muscle. Despite over eighty years passing without a single study finding any evidence 
of inflammation related to fibromyalgia, the name has stuck, even within the medical 
community. Similar to other chronic pain disorders, the inability of the medicine to 
pinpoint one specific organic pathology that could cause such pervasive pain has left the 
condition of fibromyalgia extremely vulnerable to the psychogenic explanations. 
Rommelfanger et al. describes a psychogenic condition as “a manifestation of symptoms 
that arise from a psychiatric origin, a confounding situation where an otherwise invisible 
illness becomes visible” (Rommelfanger et al., 2017). On the surface, fibromyalgia 
appears to be just that: simply a manifestation of pain with no obvious biological cause. It 
must be psychological, right? 
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As World War II came to a close, those who subscribed to the belief of the 
psychological cause of fibromyalgia felt vindicated by the increasing prevalence of 
“fibrositis” among returning soldiers. The unimaginable trauma of war must have flipped 
an internal psychological switch to cause the apparent “psychogenic rheumatism” 
experienced by so many of those veterans claiming to have unbearable widespread 
muscle pain. In 1943, almost forty years before post-traumatic stress disorder (PTSD) 
would be recognized by the American Psychiatric Association as a credible disorder, two 
U.S. military physicians offered credibility to this theory when they suggested “fibrositis” 
be renamed to “psychogenic rheumatism,” a side effect of the psychological stresses 
frequently seen in shell shocked veterans. Perhaps this is historical phenomenon lurks at 
the heart of today’s misunderstanding of fibromyalgia as having psychological origins. 
About thirty years pass before the renowned Dr. Hughe Smythe, a venerated 
Canadian physician and cofounder/coeditor of the Journal of Rheumatology, would 
abandon the term “fibrositis” and replace it with the modernly recognized term, 
fibromyalgia. Considered the “grandfather of modern fibromyalgia,” Smythe made much 
headway in specifically defining the previously ambiguous condition. He noted that 
fibromyalgia is a commonly encountered disorder characterized by chronic 
widespread musculoskeletal pain and related symptoms along with multiple painful 
“tender points,” which consist of either the right or left sides of nine areas of the body. 
Although the idea of “tender points” has been abandoned by modern day physicians, 
much of Smythe’s definition is still widely referred to in today’s medical practice in the 
diagnosis of the life-altering disorder.   
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While the symptoms of fibromyalgia are consistent among patients and fairly easy 
to identify as fibromyalgia when viewed in aggregate, the underlying molecular cause of 
the disease is still up for much debate. It is clear that genetic and environmental factors 
may play a role in the etiopathology of FMS and other chronic pain syndromes, but the 
exact reason for the physiological pain and stiffness in identified tender points remains 
elusive. As with autoimmune diseases, infectious agents (viruses in particular), 
and vaccination have all been suggested as possible triggers of FMS, but these possible 
environmental agents tell us nothing about the biological mechanism from which pain 
floods the body.  
One apparent truth about fibromyalgia is that it bears eerie similarity to 
autoimmune conditions, ringing alarm bells for many researchers who are investigating 
the possible link between autoimmunity and FMS. Autoimmune-like features of 
fibromyalgia include that it predominately affects females (90% of fibromyalgia patients 
are women) of childbearing age. However, it is more than just patient demographics that 
points to an autoimmune pathology of FMS. The connection between fibromyalgia and 
autoimmune disorders may even be so strong as to cause an increased likelihood of 
developing fibromyalgia if one already suffers from another autoimmune disease. To 
illustrate, fibromyalgia is reported in about 25 percent of patients suffering from lupus, 
25 percent of patients with rheumatoid arthritis, and 50 percent of patients with Sjogren’s 
syndrome. Likewise, recent studies have shown an overall predisposition for the 
development of FMS in patients with Hashimoto’s thyroiditis. Moreover, the co-
occurance of autoimmune diseases with FMS, especially thyroid disease, is known to 
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worsen fibromyalgia symptoms, increasing severity of pain in tender points and the 
frequency of full body fatigue (Bazzichi, Rossi, & Sarzi-Puttini, 2007). 
Multiple studies corroborate this presently unfolding story starring autoimmune 
disease and fibromyalgia. For example, three studies have found thyroid autoantibodies 
to be in greater percentages in subjects with FMS compared with controls, in spite of the 
fact that most patients have normal thyroid hormone levels. One of these studies 
synthesized previous reports of autoantibody presence in FMS patients compared to 
control subjects and noted 34.4%- 41% of FMS patients tested positive for autoantibodies 
versus 15%- 18.8% of controls (Bazzichi, Rossi, & Sarzi-Puttini, 2007). It is not just 
autoimmune thyroid disease that is a potential culprit. 
Autoantibodies to serotonin have also been found in higher than average levels in 
many patients with fibromyalgia. As a known regulator of our sleep cycle, serotonin has 
been of critical interest in the study of fibromyalgia because chronic fatigue is a common 
clinical manifestation of the disease. In a pool of 50 FMS patients, 74% showed elevated 
levels of autoantibodies to serotonin, whereas only 6% of 32 healthy (blood donor) 
controls showed the same level. Possessing high levels of autoantibodies to serotonin is 
not necessarily indicative of low serotonin blood hormone levels as one may think, 
speaking to the complicated and counterintuitive nature of autoimmunity itself. In fact, 
the same study showed that 90% of the FMS patients possessed normal levels of 
serotonin in their blood despite the elevated autoantibody concentration. This indicates 
serotonin receptor involvement, rather than a serotonin deficit, as the molecular 
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mechanism of the disease (Klein, Bansch, & Berg 1992). Then again, it is still unclear if 
serotonin is the main culprit at all in this mysterious autoimmune-like condition. 
Perhaps the most eye-opening study regarding fibromyalgia and the immune 
system is a A 2012 study in the British Journal of Medical Practitioners which noted 
another key feature of fibromyalgia pathology that involves the immune system. 
Breeding et al. propose that it is a “chronic up-regulation of the immune system with 
subsequent hormonal, connective tissue and nervous system implications” that rewires 
FMS patients’ pain circuitry to wreak havoc upon the entire body. In their rational albeit 
complex “integrated model” of FMS, an immune cascade which includes NF-[kappa]B 
be triggered by a chronic bacterial or viral infection (Breeding, Russel, & Nicholson, 
2012). You may recall that this idea bears striking resemblance to the mechanism of APS 
antibody production previously discussed, in regards to molecular mimicry. 
 
 
Why do diseases like Fibromyalgia continue to be dismissed as psychogenic? 
 Fibromyalgia is just one modern example of the concept of psychogenic diseases 
living on into the modern era. While antiphospholipid antibody syndrome and anti-
NMDA receptor encephalitis have only recently broken out of their decades-long 
research sleep, FMS has only just begun its nap. Many biomedical researchers refuse to 
acknowledge the importance of increasing knowledge of this condition, simply based on 
the perceived credibility, or lack thereof, of FMS patients. There are countless articles 
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published in respected journals and magazines within the last ten years, spewing medical 
professionals’ doubt over the existence of fibromyalgia as a legitimate medical condition.  
For example, a 2008 article published in the New Yorker entitled, “Drug 
Approved. Is Disease Real?” exposes the opinions of practicing physicians who believe 
the diagnosis of fibromyalgia is a scam perpetuated by pharmaceutical companies trying 
to sell unnecessary drugs (such as the most widely used medicinal treatment for FMS, 
Lyrica). For example, Dr. George Elrich, a practicing rheumatologist and professor at the 
University of Pennsylvania, is in the camp that asserts that everyone experiences the 
aches and pains of a supposed “fibromyalgia,” but most people are just stronger and 
better able to tolerate them. He states that people without chronic pain syndromes, 
“manage to get through life with some vicissitudes, but we adapt,” while patients with 
fibromyalgia simply “do not adapt” to equally stressful and painful situations. Dr. Nortin 
Hadler, a rheumatologist and professor of medicine at the University of North Carolina, 
joins Elrich in this state of disbelieve over fibromyalgia. He even goes as far as to state 
that FMS patients, “live under a cloud, and the more they seem to be around the medical 
establishment, the sicker they get” (Berenson, 2008).  
If fibromyalgia does show so many clinical features consistent with autoimmune 
disease, why is this disease still classified as psychogenic or questioned of its existence at 
all? For one, it is often associated with psychiatric symptoms of depression, anxiety, and 
insomnia even though there is no evidence supporting that the disease itself is causing 
these symptoms. Many believe these psychiatric symptoms are a result of the stress of 
living with this disease. In fact, recent studies have shown these negative psychological 
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symptoms to be more likely a result of the dismissal by the medical professionals, not a 
preexisting mental condition. Secondly, there are no serological markers that have been 
identified for the disease. No scan or previously developed blood tests reveal any specific 
signs of infection, autoimmunity, or inflammation. No blood test or imaging currently 
exists for FMS, so physicians have to rely on a detailed assessment of symptoms to make 
a diagnosis, and inexperienced ones unfamiliar with chronic pain often miss its confusing 
set of symptoms. This leaves FMS patients hopping from doctor to doctor, desperate for 
answers, but only accumulating doubt along the way. 
 
 
Where do we go from here? 
From our historic look at a few of medicine’s most bewildering conditions, it is 
clear that there are a multitude of labels for clinical uncertainties. From “psychogenic 
disorders” to “medically unexplained symptoms” to “functional disorders,” the medical 
community employs various jargon for the same frustration experienced by clinicians and 
patients alike. The definition, with slight variations, for all of these terms is “a 
manifestation of symptoms that arise from a psychiatric origin, a confounding situation 
where an otherwise invisible illness becomes visible” (Rommelfanger et al., 2017). 
Overall, the common thread tying APS, ANRE, and FMS together, is the fact that, at one 
point in time or another, the medical community could not identify a single biological 
cause or organic pathology that accounted for patients’ physical symptoms. For the 10 
million patients in the U.S. with fibromyalgia, the battle against the psychogenic 
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diagnosis seems never-ending, and if actions are not taken to prevent this ongoing 
struggle, the public health of our country is at stake.  
While many argue for the necessary categorization and clinical diagnoses of these 
diseases as psychogenic until proven otherwise, there is inherent danger in clinically 
labeling poorly understood diseases with such speculative and detrimental diagnoses. As 
the stories of Betty and Abagail Parris, Jan Pankish, and Susannah Cahalan have 
illustrated so clearly, mistakes made as a result of lack of scientific knowledge in 
historical eras are undoubtedly carrying through to the present. Perhaps the way to tackle 
the increasingly relevant problem of misdiagnosis in medical practices, we must start by 
learning from our mistakes of the past.  
The first step in preventing maltreatment and misdiagnosis of patients suffering 
from misunderstood diseases is acknowledgement of our historical bias against medically 
unexplained symptoms in dismissal as hysteria. Despite credible neurologists and 
psychiatrists diagnosing diseases as “psychogenic” or “functional” for decades, there are 
a few fallacies associated with psychogenic diseases that must be addressed.  
There is countless historical evidence proving that previously labeled psychogenic 
diseases are now categorized under completely different disease categories after a 
molecular cause had been determined. For example, the first two diseases outlined in this 
thesis, anti-NMDA receptor encephalitis and anti-phospholipid antibody syndrome, have 
symptoms that initially present with psychogenic symptoms (neurologic symptoms with 
no immediately apparent origin). It was only the recent discovery of serologic markers of 
blood antibodies that shifted their categorization from psychogenic to autoimmune, in 
    
55 
 
1983 and 2008 respectively. With the vast uncertainty and ever-changing nature of 
science, it would be a complete delusion to believe that all symptoms that present in 
patients that can’t be explained from an objective test are inherently a result of the 
patient’s psyche. When it is clear that science has not yet developed tests to detect the 
physiologic cause for every single human disease, as new tests are being developed every 
day, jumping to the conclusion that some diseases have no physiologic cause is to naively 
rely on science’s false omniscience.  
Secondly, some would argue that there are certain innate pros that come with 
receiving a medical diagnosis of any kind, including those deemed psychogenic, when 
they often have the opposite effect. Under this train of thought, a patient who has 
struggled with painful symptoms for a lengthy period of time might find relief in the hope 
for enhancing treatment access, availability, and effectiveness that accompanies finally 
receiving a diagnosis, albeit one psychogenic in nature. However, what many don’t 
realize is that the stigma that surrounds psychogenic patients often inhibits their access to 
treatment rather than expand it. To illustrate, psychogenic diseases are so frustrating for 
physicians, as it tests the credibility of their profession, that doctors often avoid patients 
with the label “psychogenic” at all costs, preferring to refer them to other doctors or 
dismiss their symptoms all together. Moreover, there is no specialty associated with 
psychogenic disease. Because these diseases are defined as not having a physiologic 
cause, it is easier for physicians to exclude them from their practice for not possessing a 
disease relevant to their scope of medicine. While we often associate the act of diagnosis 
with the empowering knowledge that comes with a disease label, the act of diagnosis by 
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exclusion in the case of psychogenic diseases limits treatment options and banishes 
patients as medical pariahs.  It would be more beneficial for patients to remain 
undiagnosed while completing a more thorough investigation into their symptoms, rather 
than jump to the detrimental and likely false conclusion of a psychogenic diagnosis.  
The second step that needs to be taken to prevent the neglect and misdiagnoses of 
patients suffering from misunderstood diseases is an increase in future studies conducted 
to expand our knowledge of etiopathologic causes of diseases with autoimmune features. 
While the National Institutes of Allergy and Infectious Diseases (NIAID) has estimated 
that the cost of treating autoimmune disease in the US is greater than $100 billion 
annually, the cost dedicated to autoimmune disease research is pitifully inadequate.  
To illustrate, despite autoimmunity being the second most frequent cause of 
chronic illness in the U.S., the NIH dedicates less than three percent of its annual research 
budget to autoimmune diseases. This critical gap in base biomedical research must be 
bridged to compensate for the increasing number of cases of autoimmune nature seen in 
the last decades and continued lack of knowledge regarding their molecular pathologies. 
An increased dedication to identifying the molecular pathologies of fibromyalgia and 
other autoimmune-like conditions considered “medically unexplained” will be required to 
prevent widespread patient neglect.  
  
 
 
 
    
57 
 
References 
Ahmad, J., Sohail, M. S., Khan, A., Qavi, A. H., Gaudel, P., Zahid, M., & Assad, S. 
(2017). Anti-n-Methyl-d-Aspartate-Receptor (NMDAR) Encephalitis in Association 
with Ovarian Teratoma. Cureus, 9(7), e1425. https://doi.org/10.7759/cureus.1425 
Asherson, R. A., Khamashta, M. A., Ordi-Ros, J., Derksen, R. H., Machin, S. J., 
Barquinero, J., … Hughes, G. R. (1989). Antiphospholipid syndrome: major clinical 
and serological features. Medicine, 68(6), 366–374. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/2509856 
Baker, E. W. (2015). A Storm of Witchcraft: The Salem Trials and the American 
Experience. Oxford University Press, (234). 
Bazzichi L, Rossi A, Giuliano T., (2001). Association between thyroid autoimmunity and 
fibromyalgic disease severity. Clinical Rheumatology. ; 26(12):2115-20. 
Benros, M. E., Nielsen, P. R., Nordentoft, M., Eaton, W. W., Dalton, S. O., & Mortensen, 
P. B. (2011). Autoimmune Diseases and Severe Infections as Risk Factors for 
Schizophrenia: A 30-Year Population-Based Register Study. American Journal of 
Psychiatry, 168(12), 1303–1310. https://doi.org/10.1176/appi.ajp.2011.11030516 
Buskila, D., Atzeni, F., Sarzi-Puttini, P. (2008) Etiology of fibromyalgia: The possible 
role of infection and vaccination. Autoimmunity Reviews, 8(1), 41-43. 
https://doi.org/10.1016/j.autrev.2008.07.023. 
Blumberg, J. (2007). A Brief History of the Salem Witch Trials: One Town’s Strange 
Journey from Paranoia to Pardon. Retrieved December 7, 2018, from 
    
58 
 
https://www.smithsonianmag.com/history/a-brief-history-of-the-salem-witch-trials-
175162489/ 
Cahalan, S. (2012). Brain on fire : my month of madness. Free Press. Retrieved from 
http://www.simonandschuster.com/books/Brain-on-Fire/Susannah-
Cahalan/9781451621389 
Calef, R. (1700). More wonders of the invisible world. 
http://name.umdl.umich.edu/A32160.0001.001. Accessed 3 Dec 2018 
Caporael, L. R. (1976). Ergotism: the satan loosed in Salem? Science (New York, N.Y.), 
192(4234), 21–26. https://doi.org/10.1126/SCIENCE.769159 
Dalmau, J., Gleichman A.J., Hughes, E.G., Rossi, J.E., Peng, X., Lai M., Dessain, S.K., 
Rosenfeld, M.R., Balice-Gordon, R., Lynch, D.R. (2008). Anti-NMDA-receptor 
encephalitis: case series and analysis of the effects of antibodies. The Lancet 
Neurology, 7(12), 1091-1098. Retrieved from https://doi.org/10.1016/S1474-
4422(08)70224-2. 
Dusenbery, M. (2018). Doing harm : the truth about how bad medicine and lazy science 
leave women dismissed, misdiagnosed, and sick. Retrieved from 
https://www.barnesandnoble.com/w/doing-harm-maya-
dusenbery/1123951266?ean=9780062470812#/ 
Fairweather, D., & Rose, N. R. (2004). Women and autoimmune diseases. Emerging 
Infectious Diseases, 10(11), 2005–2011. https://doi.org/10.3201/eid1011.040367 
Feldmann, E., & Levine, S. R. (1995). Cerebrovascular disease with antiphospholipid 
antibodies: immune mechanisms, significance, and therapeutic options. Annals of 
    
59 
 
Neurology, 37 Suppl 1, S114-30. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/8968222 
Flexner, A. (2002). Medical education in the United States and Canada. From the 
Carnegie Foundation for the Advancement of Teaching, Bulletin Number Four, 
1910. Bulletin of the World Health Organization, 80(7), 594–602. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/12163926 
 Friedman, J. H. (2010). Localizing the wandering uterus. Medicine and Health, Rhode 
Island, 93(5), 130–131. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/20533717 
García-Carrasco, M., Pinto, C. M., Hernández, C. J., Poblano, J. C. S., Morales, I. E., & 
Martínez, S. M. (2013). Antiphospholipid syndrome. Retrieved from 
https://www.ncbi.nlm.nih.gov/books/NBK459442/ 
Gezer, S. (2003). Antiphospholipid syndrome. Disease-a-Month, 49(12), 696–741. 
https://doi.org/10.1016/j.disamonth.2003.10.001 
Gilman, Sander L., Helen King, Roy Porter, G. S. Rousseau, and Elaine 
Showalter Hysteria Beyond Freud. Berkeley:  University of California Press,  c1993 
1993. http://ark.cdlib.org/ark:/13030/ft0p3003d3/ 
Gould, R., Miller, B. L., Goldberg, M. A., & Benson, D. F. (1986). The Validity of 
Hysterical Signs and Symptoms. The Journal of Nervous and Mental Disease, 
174(10), 593–597. https://doi.org/10.1097/00005053-198610000-00003 
Hale J. (1697) A modest enquiry into the nature of witchcraft. 
http://name.umdl.umich.edu/N00872.0001.001. Accessed 2 Dec 2018 
    
60 
 
Hall, D. (1999) Witch-Hunting in Seventeenth-Century New England. Boston: 
Northeastern University Press, (280-81) 
Hughes, E. G., Peng, X., Gleichman, A. J., Lai, M., Zhou, L., Tsou, R., … Balice-
Gordon, R. J. (2010). Cellular and synaptic mechanisms of anti-NMDA receptor 
encephalitis. The Journal of Neuroscience : The Official Journal of the Society for 
Neuroscience, 30(17), 5866–5875. https://doi.org/10.1523/JNEUROSCI.0167-
10.2010 
Klein R, Bansch M, Berg PA. Clinical relevance of antibodies against serotonin and 
gangliosides in patients with primary fibromyalgia syndrome. 
Psychoneuroendocrinology. 1992;17(6):593-8. 
Lahita, R. G., & Yalof, I. L. (2005). Women and Autoimmune Disease: The Mysterious 
Ways Your Body Betrays Itself. New York: HarperCollins. 
Lawson D (1692) A brief and true narrative of some remarkable passages relating to 
sundry persons afflicted by witchcraft at Salem village. 
http://name.umdl.umich.edu/A49794.0001.001.Accessed 3 Dec 2018 
Levine, S. R., Deegan, M. J., Futrell, N., & Welch, K. M. (1990). Cerebrovascular and 
neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology, 
40(8), 1181–1189. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/2381525 
Liu, C., Zhu, J., Zheng, X.-Y., Ma, C., & Wang, X. (2017). Anti-N-Methyl-D-aspartate 
Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis. 
Mediators of Inflammation, 2017, 1–14. https://doi.org/10.1155/2017/6361479 
    
61 
 
Maneta, E., & Garcia, G. (2014). Psychiatric Manifestations of Anti-NMDA Receptor 
Encephalitis: Neurobiological Underpinnings and Differential Diagnostic 
Implications. Psychosomatics, 55(1), 37–44. 
https://doi.org/10.1016/J.PSYM.2013.06.002 
More, E. (1987). The Blackwell Medical Society and the Professionalization of Women 
Physicians. Bulletin of the History of Medicine, 61(4), 603–628. Retrieved from 
http://dml.regis.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&d
b=ahl&AN=45953978&site=ehost-live&scope=site 
Mueller, S. H., Färber, A., Prüss, H., Melzer, N., Golombeck, K. S., Kümpfel, T., … 
German Network for Research on Autoimmune Encephalitis (GENERATE). (2018). 
Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis. Annals of 
Neurology, 83(4), 863–869. https://doi.org/10.1002/ana.25216 
Najjar, S., Pearlman, D. M., Alper, K., Najjar, A., & Devinsky, O. (2013). 
Neuroinflammation and psychiatric illness. Journal of Neuroinflammation, 10, 43. 
https://doi.org/10.1186/1742-2094-10-43 
Najjar, S., Steiner, J., Najjar, A., & Bechter, K. (2018). A clinical approach to new-onset 
psychosis associated with immune dysregulation: the concept of autoimmune 
psychosis. Journal of Neuroinflammation, 15(1), 40. https://doi.org/10.1186/s12974-
018-1067-y 
Nakazawa, D. J. (2008). The autoimmune epidemic : bodies gone haywire in a world out 
of balance-- and the cutting-edge science that promises hope. Simon & Schuster. 
    
62 
 
Retrieved from https://www.amazon.com/Autoimmune-Epidemic-Balance-Cutting-
Edge-Promises-ebook/dp/B0012ZKZM0 
Neurobehavioral presentations of the antiphospholipid antibody syndrome. (1993). The 
Journal of Neuropsychiatry and Clinical Neurosciences, 5(1), 37–42. 
https://doi.org/10.1176/jnp.5.1.37 
Newcomer, J. W., Farber, N. B., & Olney, J. W. (2000). NMDA receptor function, 
memory, and brain aging. Dialogues in Clinical Neuroscience, 2(3), 219–232. 
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22034391 
Rice, JS., Kowal C., Volpe B.T., Degiorgio L.A., Diamond B. (2005) Molecular 
mimicry: anti-DNA antibodies bind microbial and nonnucleic acid self-
antigens. Curr Top Microbiol Immunol 2005; 296:137–151 Medline, Google Scholar 
Sangle, N. A., & Smock, K. J. (2011). Antiphospholipid Antibody Syndrome. Archives of 
Pathology & Laboratory Medicine, 135(9), 1092–1096. 
https://doi.org/10.5858/2010-0325-RSR.1 
Schiff, S. (2015). The Witches of Salem: Diabolical Doings in the Puritan Village. 
Retrieved December 7, 2018, from 
https://www.newyorker.com/magazine/2015/09/07/the-witches-of-salem 
Steiner, J., Mawrin, C., Ziegeler, A., Bielau, H., Ullrich, O., Bernstein, H.-G., & Bogerts, 
B. (2006). Distribution of HLA-DR-positive microglia in schizophrenia reflects 
impaired cerebral lateralization. Acta Neuropathologica, 112(3), 305–316. 
https://doi.org/10.1007/s00401-006-0090-8 
    
63 
 
Stojanovich, L., & Marisavljevich, D. (2008). Stress as a trigger of autoimmune disease. 
Autoimmunity Reviews, 7(3), 209–213. 
https://doi.org/10.1016/J.AUTREV.2007.11.007 
Tam, J., & Zandi, M. S. (2017). The witchcraft of encephalitis in Salem. Journal of 
Neurology, 264(7), 1529–1531. https://doi.org/10.1007/s00415-017-8546-4 
Tasca, C., Rapetti, M., Carta, M. G., & Fadda, B. (2012). Women and hysteria in the 
history of mental health. Clinical Practice and Epidemiology in Mental Health : CP 
& EMH, 8, 110–119. https://doi.org/10.2174/1745017901208010110 
Te-Yu Hung, Ning-Hui Foo, Ming-Chi Lai (2011). Anti-N-Methyl-d-Aspartate Receptor 
Encephalitis, Pediatrics & Neonatology, 52(7), 361-364, 
https://doi.org/10.1016/j.pedneo.2011.08.012. 
Uszkalo, K. C. (2012). Medical Theories on Malefic Possession: From Bewitchment to 
Anti-NMDAR Encephalitis. Journal of Religion in Europe, 5, 323–348. 
https://doi.org/10.1163/18748929-00503001 
Vahter, L., Kannel, K., Sorro, U., Jaakmees, H., Talvik, T., & Gross-Paju, K. (2014). 
Cognitive dysfunction during anti-NMDA-receptor encephalitis is present in early 
phase of the disease. Oxford Medical Case Reports, 2014(4), 74–76. 
https://doi.org/10.1093/omcr/omu028 
Vlachoyiannopoulos, P. G., & Routsias, J. G. (2010). A novel mechanism of thrombosis 
in antiphospholipid antibody syndrome. Journal of Autoimmunity, 35(3), 248–255. 
https://doi.org/10.1016/j.jaut.2010.06.015 
 
